198 related articles for article (PubMed ID: 16026267)
1. Molecular targets of diabetic cardiovascular complications.
Ahmad FK; He Z; King GL
Curr Drug Targets; 2005 Jun; 6(4):487-94. PubMed ID: 16026267
[TBL] [Abstract][Full Text] [Related]
2. [Pathogenesis and therapeutic targets of diabetic microvascular complications].
Li H
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 May; 35(3):233-7. PubMed ID: 16764022
[No Abstract] [Full Text] [Related]
3. Aldose reductase in diabetic microvascular complications.
Chung SS; Chung SK
Curr Drug Targets; 2005 Jun; 6(4):475-86. PubMed ID: 16026266
[TBL] [Abstract][Full Text] [Related]
4. The role of protein kinase C activation and the vascular complications of diabetes.
Das Evcimen N; King GL
Pharmacol Res; 2007 Jun; 55(6):498-510. PubMed ID: 17574431
[TBL] [Abstract][Full Text] [Related]
5. Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction.
Szabo C
Br J Pharmacol; 2009 Mar; 156(5):713-27. PubMed ID: 19210748
[TBL] [Abstract][Full Text] [Related]
6. Molecular understanding of hyperglycemia's adverse effects for diabetic complications.
Sheetz MJ; King GL
JAMA; 2002 Nov; 288(20):2579-88. PubMed ID: 12444865
[TBL] [Abstract][Full Text] [Related]
7. Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications.
Xu Y; He Z; King GL
Curr Diab Rep; 2005 Apr; 5(2):91-7. PubMed ID: 15794910
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of diabetic angiopathy--clues for innovative therapeutic interventions.
Bierhaus A; Ziegler R; Nawroth PP
Horm Res; 1998; 50 Suppl 1():1-5. PubMed ID: 9676989
[TBL] [Abstract][Full Text] [Related]
9. [Role of polyol pathway in pathogenesis of diabetic microangiopathy].
Nakamura J
Nihon Rinsho; 2005 Jun; 63 Suppl 6():52-61. PubMed ID: 15999685
[No Abstract] [Full Text] [Related]
10. Hyperglycemia and the pathobiology of diabetic complications.
Aronson D
Adv Cardiol; 2008; 45():1-16. PubMed ID: 18230953
[TBL] [Abstract][Full Text] [Related]
11. Molecular complexities underlying the vascular complications of diabetes mellitus - A comprehensive review.
Paul S; Ali A; Katare R
J Diabetes Complications; 2020 Aug; 34(8):107613. PubMed ID: 32505477
[TBL] [Abstract][Full Text] [Related]
12. The missing link: a single unifying mechanism for diabetic complications.
Nishikawa T; Edelstein D; Brownlee M
Kidney Int Suppl; 2000 Sep; 77():S26-30. PubMed ID: 10997687
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory pathways.
Navarro-González JF; Mora-Fernández C
Contrib Nephrol; 2011; 170():113-123. PubMed ID: 21659764
[TBL] [Abstract][Full Text] [Related]
14. Diabetic microangiopathy: Pathogenetic insights and novel therapeutic approaches.
Madonna R; Balistreri CR; Geng YJ; De Caterina R
Vascul Pharmacol; 2017 Mar; 90():1-7. PubMed ID: 28137665
[TBL] [Abstract][Full Text] [Related]
15. The role of AGEs and AGE inhibitors in diabetic cardiovascular disease.
Thomas MC; Baynes JW; Thorpe SR; Cooper ME
Curr Drug Targets; 2005 Jun; 6(4):453-74. PubMed ID: 16026265
[TBL] [Abstract][Full Text] [Related]
16. Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy.
Yamagishi S; Imaizumi T
Curr Pharm Des; 2005; 11(18):2279-99. PubMed ID: 16022668
[TBL] [Abstract][Full Text] [Related]
17. [Possible participation of advanced glycation endproducts and their receptor system in the development of diabetic vascular complications].
Yamamoto Y; Sakurai S; Watanabe T; Yonekura H; Yamamoto H
Nihon Yakurigaku Zasshi; 2003 Jan; 121(1):49-55. PubMed ID: 12617038
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the pathogenesis of microvascular complications in diabetes.
Park S; Kang HJ; Jeon JH; Kim MJ; Lee IK
Arch Pharm Res; 2019 Mar; 42(3):252-262. PubMed ID: 30771210
[TBL] [Abstract][Full Text] [Related]
19. The cellular and molecular mechanisms of diabetic complications.
King GL; Brownlee M
Endocrinol Metab Clin North Am; 1996 Jun; 25(2):255-70. PubMed ID: 8799700
[TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular mechanisms of vascular injury in diabetes--part I: pathways of vascular disease in diabetes.
Madonna R; De Caterina R
Vascul Pharmacol; 2011; 54(3-6):68-74. PubMed ID: 21453786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
